Blog

The latest thoughts from Medicines Law & Policy partners.

The European Commission’s compulsory licensing proposals are sensible but do not go far enough

An earlier version of this comment was published in Barron's on 21 July 2023. A Spanish translation of it is also available from El...

WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis

An earlier version of this comment was published by The Wire on 13 October 2020. On 2 October, India and South Africa sent a proposal...

Urgent collective action to meet the challenge of this pandemic crisis: a coronavirus related...

The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, first described the present coronavirus (COVID-19) outbreak as a pandemic on the 11th...

Will the European Court of Justice put a stop to the evergreening of Truvada...

Truvada, the fixed-dose combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is a critical medicine in both HIV treatment and prevention. It is...

The new EU compulsory licensing regime needs to allow the export of medicines

Guest author Olga Gurgula is a Senior Lecturer in Intellectual Property Law at Brunel Law School, Brunel University London. A war-weary Ukraine critically depends on the support of...

The Power of TRIPS Flexibilities in Medicines Procurement

The government of Malaysia has began to roll out treatment of people infected with the hepatitis C virus (HCV).  Treatment will be a combination of...

Dutch Health Care Institute Says No to Medicines Pirate

It seems the Dutch health care system and health care professionals are fed up with the abuse of the orphan medicines regulation, which is...

Decision on intellectual property waiver over Covid technology on hold till 2021; what are...

Note: This article was edited on 19 December to include a statement from the EU supporting sharing of intellectual property, technology, and know-how transfer. The...

New Database Documents the Power of TRIPS Flexibilities

Medicines Law & Policy has published an on-line database of instances of the use of TRIPS flexibilities in public health contexts, titled the TRIPS...

The Most Common Misunderstanding about Compulsory Licensing

The belief that a country can only use compulsory licensing in cases of public health emergencies is a myth that has proven difficult to...